OHLCX Market Research
Delayed

LABD

LABD, or Direxion Daily S&P Biotech Bear 3X Shares, is an exchange-traded fund (ETF) designed to provide three times the inverse of the daily performance of the S&P Biotechnology Select Industry Index. LABD seeks to deliver -3x the daily return of the underlying index.

+0.59 (+7.02%) Nov 20, 2026 19:28 ET Delayed
Open
8.58
High
9.16
Low
8.18
Prev close
8.41
Volume
19M
Avg vol 10
25M

Today · Market closed · opens Mon 9:30 AM

Price

LABD chart

Updating chart…

Scroll or pinch to zoom, drag to pan, or use the buttons on the chart. About the price history

Signals

Technical analysis

Daily bars · last bar Nov 20, 2026 · close 9.00

Strong sellNeutralStrong buy
Buy
score +0.17 · 18 signalling
7Buy
7Neutral
4Sell

Leaning buy. 7 of 18 signals point up against 4 down, carried by momentum and trend. Volatility leans sell. Volume is mostly neutral. Stochastic, Stoch RSI, Williams %R and CCI sit in overbought territory. Trend strength is weak (ADX 15).

How to read this →

Trend

MACD 12, 26, 9
Above signal line and zero
MACD 0.24 · Signal 0.04 · Hist +0.21
Buy
ADX 14
Weak trend, +DI ahead
ADX 14.52 · +DI 28.63 · −DI 14.81
Neutral
Parabolic SAR 0.02, 0.2
Below price, 2.29 under the close
6.71
Buy
Ichimoku 9, 26, 52
Price above cloud, conversion above base
Conv 7.81 · Base 7.79 · A 7.84 · B 7.49
Buy

Momentum

RSI 14
Above midpoint, not overbought
63.27
Neutral
Stoch 14, 3
Overbought, %K still above %D
%K 94.12 · %D 91.37
Neutral
Stoch RSI 14, 14, 3, 3
Overbought, %K level with %D
%K 100.00 · %D 100.00
Neutral
Williams %R 14
Overbought zone, still rising
−5.88
Neutral
CCI 14
Above +100, still rising
163.86
Neutral
MFI 14
Above midpoint, not overbought
58.74
Neutral
ROC 12
Price up 38.25% over 12 bars
+38.25%
Buy
AO 5, 35
Above zero and rising
0.49
Buy
TRIX 18
Just below zero
−0.004
Sell
KST 10/15/20/30, 3
Above its signal line
KST 9.81 · Signal −10.68
Buy

Volatility

Bollinger 20, 2
Above the upper band
Up 8.79 · Mid 7.42 · Low 6.05
Sell
Keltner 20, 10, 1.5
Above the upper channel
Up 8.83 · Mid 7.71 · Low 6.59
Sell

Volume

VWAP 345-bar
Close 1.2% below VWAP
9.11
Sell
Force Index 1
Positive, buyers in control
11.4M
Buy
ATR
0.73
8.12% of close
A/D Line
−215.7M
cumulative
OBV
−238.1M
cumulative
Volume Profile
4.32 – 7.11
POC · bull 852.9M · bear 1.05B · 45 / 55
Risk and return

Performance

Daily returns for Jan 1, 2026 – Nov 22, 2026 (YTD). About the returns · About the risk figures

1 month return

19.55%

Change in value over the past month.

3 month return

40.59%

Change in value over the last three months.

Max drawdown

73.22%

Largest fall from a peak to the low that followed.

Standard deviation

93.09%

How far daily returns stray from their average, annualised.

Sharpe ratio

-0.56

Return above the risk-free rate per unit of volatility.

Calmar ratio

-0.71

Annualised return against the maximum drawdown.

About

LABD summary

Loading summary…

Questions

LABD, answered

What is the expense ratio of LABD?

LABD has an expense ratio of approximately 1.07%. This fee covers the costs of managing the fund, including administrative and operational expenses, expressed as a percentage of the fund’s average net assets.

Can LABD be used in a retirement account?

Yes, LABD can be held in retirement accounts such as IRAs or 401(k)s. However, due to its high-risk, leveraged nature, it is essential to consider how it fits within your overall investment strategy and risk tolerance.

What are the risks associated with investing in LABD?

Risks include high volatility and potential for significant losses due to LABD’s leveraged inverse exposure. The ETF's performance is highly sensitive to daily movements in the biotech sector, and leverage can amplify both gains and losses.

How is LABD managed?

LABD is managed by Direxion Funds and employs leverage through financial instruments such as futures contracts, options, and swap agreements. The fund aims to maintain its -3x leverage ratio through daily rebalancing.

How does LABD’s use of leverage impact its performance?

LABD uses leverage to amplify its inverse exposure to the biotech sector, targeting -3x the daily performance of the S&P Biotechnology Select Industry Index. Leverage can lead to significant performance fluctuations, particularly over periods longer than one day due to compounding effects.

What are the key performance metrics for LABD?

Key performance metrics for LABD include its net asset value (NAV), expense ratio, daily return performance, and leverage ratio. LABD targets -3x the daily performance of the S&P Biotechnology Select Industry Index.

How can I invest in LABD?

Investors can buy shares of LABD through a brokerage account. The ETF is traded on major stock exchanges under the ticker symbol "LABD" and can be bought and sold like other stocks and ETFs.

What factors can affect the performance of LABD?

Factors influencing LABD’s performance include movements in the biotech sector, changes in the S&P Biotechnology Select Industry Index, market volatility, and the effects of leverage. LABD’s daily rebalancing and compounding effects also impact performance.

How does LABD’s performance compare to the S&P Biotechnology Select Industry Index?

LABD aims to deliver three times the inverse (-3x) of the daily performance of the S&P Biotechnology Select Industry Index. Over time, due to the effects of compounding and daily rebalancing, its performance may differ significantly from the index.

What are some similar ETFs to LABD?

Similar ETFs to LABD include: LABU (Direxion Daily S&P Biotech Bull 3X Shares), which seeks to provide 3x the daily performance of the S&P Biotechnology Select Industry Index, the opposite of LABD’s objective; XBI (SPDR S&P Biotech ETF), which provides exposure to the biotechnology sector without leverage; and BIB (Direxion Daily S&P Biotech Bull 2X Shares), which provides 2x the daily performance of the S&P Biotechnology Select Industry Index, less leveraged compared to LABD.

Unleash Your LABD Trading Now

Experience the future of trading with OHLCX Markets. Our advanced system delivers in-depth analysis and insights for LABD, utilizing state-of-the-art technical tools and strategies. Transform your trading strategy now and see how we can elevate your trading results!

Enhance Your Trading Now

Disclaimers

The information displayed on this site is sourced from third-party providers and is believed to be reliable. OHLCX has not independently verified this data and does not guarantee its accuracy. Content is for educational and informational purposes only and is not financial or investment advice.

With any investment, your capital is at risk. Past performance is no guarantee of future results. Consult your provider's terms and privacy policies where applicable.

Prices, charts and every figure derived from them are delayed by at least 15 minutes and are provided for information only; we do not guarantee their accuracy or timeliness.

Securities products are: Not FDIC insured · Not bank guaranteed · May lose value

Trademarks and logos are the property of their respective owners and do not represent endorsements of any kind.